Lilly says gene editing therapy cut “bad” cholesterol in early-stage trial
Eli Lilly & Co. · PHARMACEUTICAL PREPARATIONS · Now $1105.00
+2.5% in 3d after detection
Post-detection moves
1h
-0.2%
1d
+0.4%
3d
+2.5%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS